Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates

Sophie Jones, Lynn Grignard, Issa Nebie, Jaffu Chilongola, Daniel Dodoo, Robert Sauerwein, Michael Theisen, Will Roeffen, Shrawan Kumar Singh, Rajesh Kumar Singh, Sanjay Singh, Eric Kyei-Baafour, Kevin Tetteh, Chris Drakeley, Teun Bousema
Publication year: 


Pfs48/45 and Pfs230 are P. falciparum sexual stage proteins and promising malaria transmission-blocking vaccine candidates. Antibody responses against these proteins may be naturally acquired and target antigens may be under selective pressure. This has consequences for the future evaluation of vaccine immunogenicity and efficacy in populations naturally exposed to malaria.


We determined naturally acquired antibody responses to the recombinant proteins Pfs48/45 -10C and Pfs230-230CMB in children from three malaria endemic settings in Ghana, Tanzania and Burkina Faso. We also examined genetic polymorphisms in the P. falciparum gene pfs48/45.


Antibody prevalence was 1.1-18.2% for 10C and 6.7-18.9% for 230CMB. In Burkina Faso we observed evidence of an age-dependent acquisition pattern for both 10C (p<0.001) and 230CMB (p=0.031). Membrane feeding assays on a separate dataset demonstrated an association between functional transmission reducing activity and antibody prevalence for both 10C (p=0.017) and 230CMB (p=0.049). 17 single nucleotide polymorphisms were found inpfs48/45 (from 126 samples), with 5 non-synonymous SNPs in the Pfs48/45 10C region.


We conclude there are naturally acquired antibody responses to both vaccine candidates which have functional relevance by reducing the transmissibility of infected individuals. We identified genetic polymorphisms, in pfs48/45which exhibited geographical specificity.